跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADDITIVE SOLUTION FORMULA 3 AS-3 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ADDITIVE SOLUTION FORMULA 3 AS-3
Authorized
STANDARD
ADDITIVE SOLUTION FORMULA 3 AS-3
TERUMO BCT, INC.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8435f3ede78fb70d
Company
TERUMO BCT, INC.
Type
Standard
Approval Details
Approval Id
8435f3ede78fb70d
Drug Approval Canada Name
ADDITIVE SOLUTION FORMULA 3 AS-3
Product Name
ADDITIVE SOLUTION FORMULA 3 AS-3
Status
Marketed
Status Date
2013-05-31
Original Market Date
2013-05-31
Din
02324393
Drug Class
Human
Dosage Form
Solution
Route Of Administration
0-Unassigned
Schedule
Ethical
Ahfs
20:12.04.92
Atc Original
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Atc Name
v 07 ac
Aig Number
0652546001
Company Name
TERUMO BCT, INC.
Company Address
10811 W Collins Ave, Lakewood, Colorado, United States, 80215
Company Detail Path
/organization/terumo-bct-inc
Company Information
Pharmaceutical Company Name
TERUMO BCT, INC.
Country Name
United States
Province Name
Colorado
City Name
lakewood,colorado,country_us
Address
1158 West Collins Ave
Active Ingredients
ADENINE
0.030 G / 100 ML
CITRIC ACID MONOHYDRATE
0.042 G / 100 ML
DEXTROSE
1.10 G / 100 ML
SODIUM CHLORIDE
0.410 G / 100 ML
SODIUM CITRATE DIHYDRATE
0.588 G / 100 ML
SODIUM PHOSPHATE MONOBASIC, MONOHYDRATE
0.276 G / 100 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8435f3ede78fb70d
Type
Standard
Back to Health Canada Approvals